⌕
Establishment Labs Holdings · ESTA · Nasdaq
Tenet 30 · Weak
Compare
$69.51−0.44%At closeTenet 30 · Weak
$69.51−0.31 (−0.44%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Establishment Labs Holdings (ESTA) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

● Seeking AlphaOct 29, 2026 · 12:38 ETEARNINGS EXPECTED BY JAN 29
Establishment Labs Holdings Inc. (ESTA) Q3 2026 Earnings Call Transcript

Establishment Labs Holdings Inc. (ESTA) Q3 2026 Earnings Call Transcript…

● Zacks Investment ResearchOct 29, 2026 · 11:31 ETEARNINGS EXPECTED BY JAN 29
Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Beats Revenue Estimates

Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.38 per share a year ago.…

● MarketBeatOct 29, 2026 · 10:05 ETEARNINGS EXPECTED BY JAN 29
What Establishment Labs (ESTA) Said on Its Q3 Earnings Call

Establishment Labs NASDAQ: ESTA reported third-quarter revenue growth of 33.9% year over year to $72 million, driven by U.S. market-share gains and expansion across international markets, while the company generated posi…

● Business WireOct 29, 2026 · 08:00 ETEARNINGS EXPECTED BY JAN 29
Establishment Labs® Reports Third Quarter 2026 Financial Results

NEW YORK--(BUSINESS WIRE)---- $ESTA #Breast--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and r…

● Zacks Investment ResearchOct 22, 2026 · 11:02 ETEARNINGS EXPECTED BY JAN 29
Establishment Labs Holdings Inc. (ESTA) Expected to Beat Earnings Estimates: Should You Buy?

Establishment Labs (ESTA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.…

● Business WireOct 19, 2026 · 08:00 ETEARNINGS EXPECTED BY JAN 29
Establishment Labs® to Announce Third Quarter 2026 Financial Results on October 29

NEW YORK--(BUSINESS WIRE)---- $ESTA #Breast--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and r…

● Defense WorldOct 7, 2026 · 08:17 ET
Contrasting Establishment Labs (NASDAQ:ESTA) & OraSure Technologies (NASDAQ:OSUR)

Establishment Labs (NASDAQ: ESTA - Get Free Report) and OraSure Technologies (NASDAQ: OSUR - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will compare the two companies b…

● Business WireOct 5, 2026 · 08:00 ET
Establishment Labs® Receives FDA Approval for Additional Sizes of Motiva Implants®

NEW YORK--(BUSINESS WIRE)---- $ESTA #Breast--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and r…

● Business WireSep 21, 2026 · 08:00 ET
Establishment Labs® Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic Implants

NEW YORK--(BUSINESS WIRE)---- $ESTA #Breast--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and r…

● Defense WorldSep 21, 2026 · 02:15 ET
Establishment Labs Holdings Inc. (NASDAQ:ESTA) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of Establishment Labs Holdings Inc. (NASDAQ: ESTA - Get Free Report) have been assigned an average rating of "Moderate Buy" from the nine research firms that are presently covering the firm, MarketBeat reports. On…

● Seeking AlphaSep 9, 2026 · 05:36 ETEARNINGS EXPECTED BY JAN 29
Establishment Labs: Procedure Economics Strengthens The Bull Case

Establishment Labs is leveraging FDA approval and U.S. market entry to drive higher-margin growth through procedure-based offerings like Preservé. Q2 2026 results showed 31.7% revenue growth, gross margin expansion to 70…

● Defense WorldAug 27, 2026 · 02:16 ET
Establishment Labs Holdings Inc. (NASDAQ:ESTA) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of Establishment Labs Holdings Inc. (NASDAQ: ESTA - Get Free Report) have been given an average recommendation of "Moderate Buy" by the nine ratings firms that are currently covering the stock, Marketbeat Ratings …

● Defense WorldAug 24, 2026 · 03:54 ETEARNINGS EXPECTED BY JAN 29
Deutsche Bank AG Buys New Holdings in Establishment Labs Holdings Inc. $ESTA

Deutsche Bank AG purchased a new position in shares of Establishment Labs Holdings Inc. (NASDAQ: ESTA) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission…

No recent releases where the company itself is speaking.

Kept in their own lane. A press release is the company talking, not reporting.

Expected by Jan 29. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.

NVDA31−0.4%
WDAY4−5.8%
BBW3−2.6%

Article counts from the last market-wide feed page, across every symbol we track and not just ESTA · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.